BFSG, LLC

Position in OGN — Organon & Co.

CIK 1706836 IRVINE, CA

Position in OGN

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$393,445

+$195,967 QoQ

Shares Held

29,058

-11.9% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#21

of 185 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

BFSG, LLC holds $27,089,521 across 12 Drug Manufacturers - General names. OGN ranks #8 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	22,116	$5,565,270
2	JNJ	Johnson & Johnson	21,466	$5,451,720
3	AMGN	Amgen Inc	13,879	$5,025,863
4	MRK	Merck & Co., Inc.	35,943	$4,618,675
5	LLY	ELI LILLY & Co	3,326	$3,989,304
6	PFE	Pfizer Inc	50,722	$1,221,385
7	NVO	Novo Nordisk A S	12,243	$586,929
8	OGN	Organon & Co. This page	29,058	$393,445

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$393,445	29,058	-11.9%	Shares	Sole	2026-07-20
2026-03-31	$197,478	32,968	+1.8%	Shares	Sole	2026-04-29
2025-12-31	$232,221	32,388	+41.6%	Shares	Sole	2026-01-22
2025-09-30	$244,358	22,880	-3.1%	Shares	Sole	2025-10-29
2025-06-30	$228,544	23,610	+44.8%	Shares	Sole	2025-07-15
2025-03-31	$242,707	16,300	-4.0%	Shares	Sole	2025-04-18
2024-12-31	$253,341	16,980	+13.8%	Shares	Sole	2025-01-31
2024-09-30	$285,419	14,920	+0.9%	Shares	Sole	2024-10-16
2024-06-30	$305,946	14,780	-19.9%	Shares	Sole	2024-07-29
2024-03-31	$346,972	18,456	0.0%	Shares	Sole	2024-04-23
2023-12-31	$266,135	18,456	+78.1%	Shares	Sole	2024-04-23
2023-09-30	$179,936	10,365	—	Shares	Sole	2023-10-20
No filing history on record for this holder in this stock.